Supporting Expertise and Formulation Technologies

In addition to our dedicated research in the area of Nucleic Acid Delivery, we conduct research and have expertise in a wide range of complementary areas, which can support research in nucleic acid therapeutics.

Research Area: Lyophilisation

Investigator

Key Papers

Prof Abina Crean and Dr Sonja Vucen

Application of a mixture DOE for the prediction of formulation critical temperatures during lyophilisation process optimisation

Fluorescence spectroscopy for the determination of reconstitution time of an in-vial lyophilised product

Research Area: Machine Learning

Investigator

Key Papers

Prof Brendan Griffin, Dr Joey O'Shea and Dr Patrick O'Dwyer

Applying Computational Predictions of Biorelevant Solubility Ratio Upon Self-Emulsifying Lipid-Based Formulations Dispersion to Predict Dose Number

Artificial Neural Networks to Predict the Apparent Degree of Supersaturation in Supersaturated Lipid-Based Formulations: A Pilot Study

Research Area: Physiologically Based Biopharmaceutics modelling

Investigator

Key Papers

Prof Brendan Griffin, Dr Joey O'Shea, Dr Patrick O'Dwyer and Dr Sonja Vucen

On the usefulness of four in vitro methods in assessing the intraluminal performance of poorly soluble, ionisable compounds in the fasted state

Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments

Research Area: Regulatory Science

Investigator

Key Papers

Prof Brendan Griffin and Dr Patrick O'Dwyer

Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland

Regulation of biosimilar medicines and current perspectives on interchangeability and policy

Research Area: In vivo preclinical models

Investigator

Key Papers

Prof Brendan Griffin and Dr Joey O'Shea

The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review

Pre-clinical evaluation of a modified cyclodextrin-based nanoparticle for intestinal delivery of Liraglutide

Research Area: Nanoparticle Preparation

Investigator	Key Paper
Dr Sonja Vucen	A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization

RNAMEDs homepage

School of Pharmacy

Cógaisíocht

Pharmacy Building Room UG06 University College Cork

Top